Intensified competition in the pharmaceutical industry will put forward higher requirements for the pharmaceutical machine industry

In recent years, with the continuous advancement of pharmaceutical reform, the integration speed of the pharmaceutical industry is further accelerating. At the same time, the intensified competition among pharmaceutical companies has gradually become the general trend of the industry. Affected by this, the industry generally believes that in order to better promote the development of the pharmaceutical industry, pharmaceutical companies need to continuously carry out technological innovation to promote the transformation, upgrading and high-quality development of the pharmaceutical industry. It is worth noting that people in the industry believe that promoting the transformation and upgrading and high-quality development of the pharmaceutical industry is bound to lack the strong assistance of pharmaceutical equipment. Based on this, the pharmaceutical equipment industry is also expected to usher in more new opportunities for development under the intensified competition in the pharmaceutical industry. It is understood that pharmaceutical equipment refers to chemical raw materials and pharmaceuticals, Chinese medicine decoction pieces and special production equipment for Chinese patent medicine. Tanks, liquid storage tanks, liquid dispensing tanks, blister packaging machines, granule packaging machines, powder packaging machines, V-type mixers, lifting feeders, etc. For a long time, pharmaceutical equipment has played an irreplaceable role in the transformation and upgrading of the pharmaceutical industry, as well as in enhancing the competitiveness of enterprises and ensuring drug safety. As we all know,“If a worker wants to do a good job, he must first sharpen his tools”, In order to better promote the development of my country's pharmaceutical industry, in recent years, many pharmaceutical equipment companies in my country have begun to adapt to market demand, accelerate technological innovation, expand cooperation with foreign countries, and improve the manufacturing level of China's pharmaceutical equipment at a higher level and in a wider range. and production capacity, towards the trend of integration, automation and intelligence. For example, in 2019, Xinma Pharmaceutical began to build a high-end pharmaceutical equipment industrialization project. It is expected that after the project is completed and put into operation, the sales revenue will reach 1.2 billion yuan and the annual profit will be 180 million yuan. It is worth mentioning that the launch of this project not only means that the technological innovation of Xinma Pharmaceutical will be further upgraded, but also will form a whole industrial chain of solid preparations-laboratory, customized, production-type, and closed-type production lines. Domestic and foreign customers provide a complete solution provider of stable and reliable solid preparation equipment. In addition, in the face of the huge wave of Industry 4.0, Tofflon is also accelerating the upgrade of pharmaceutical equipment, and continues to innovate on the basis of equipment automation. It is understood that the overall turnkey project launched by it covers the design of the production line layout, the optimization scheme of equipment integration and automated production, digital monitoring, information-based remote management, etc.“Smart Pharmaceutical Factory”multi-directional function. According to reports, the“Intelligent pharmaceutical factory”It will also directly drive the company from the 10 billion market scale of freeze-drying systems to the 100 billion market space of pharmaceutical factory equipment, process systems and services. Although the current domestic pharmaceutical equipment industry is developing very rapidly, and the product quality and technology have been greatly improved compared with the past; but in comparison, most domestic enterprises have been mainly producing medium and low-end products. Pharmaceutical equipment produced by foreign companies in the market has always had more advantages. Therefore, the industry believes that in order to shorten the gap and further enhance the product competitiveness and market share of domestic pharmaceutical equipment, domestic pharmaceutical equipment companies still have a long way to go. In a word, with the intensification of industry competition and the increasing attention of the public to drug safety, pharmaceutical companies will put forward higher requirements for the safety, production efficiency and stability of pharmaceutical equipment in the future. In this context, the industry suggests that in addition to improving the automation, digitization and intelligence of equipment, pharmaceutical equipment companies need to explore the application of more new supporting technologies and devices according to the actual situation, such as PAT technology, robotics, 3D printing technology etc., to further expand the functionality of the product to better meet the needs of pharmaceutical companies.